| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9797 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5755 |
| P-glycoprotein Substrate | Non-substrate | 0.7324 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9367 |
| Non-inhibitor | 0.8823 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8603 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5243 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7830 |
| CYP450 2D6 Substrate | Non-substrate | 0.8934 |
| CYP450 3A4 Substrate | Non-substrate | 0.5279 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5199 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9642 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9709 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9072 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9188 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9843 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8407 |
| Non-inhibitor | 0.8737 |
| AMES Toxicity | Non AMES toxic | 0.7961 |
| Carcinogens | Non-carcinogens | 0.9049 |
| Fish Toxicity | Low FHMT | 0.5444 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9304 |
| Honey Bee Toxicity | Low HBT | 0.8561 |
| Biodegradation | Not ready biodegradable | 0.8856 |
| Acute Oral Toxicity | III | 0.5105 |
| Carcinogenicity (Three-class) | Non-required | 0.6853 |